Detecting markers of therapy-induced senescence in cancer cells

Dorothy NY Fan , Clemens A Schmitt
Oncogene-Induced Senescence: Methods and Protocols 41 -52

14
2017
Exploiting drug-induced senescence in transgenic mouse models

Mehtap Kilic , Clemens A Schmitt
CRC Press 287 -308

2
2008
critical issues in lymphoma management

David Fuchs , Clemens A Schmitt
memo-Magazine of European Medical Oncology 12 ( 1) 1 -1

2019
Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.

Megan J. Bywater , Gretchen Poortinga , Elaine Sanij , Nadine Hein
Cancer Cell 22 ( 1) 51 -65

336
2012
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.

Patrizia Mondello , Caterina Musolino , Irene Dogliotti , Jan‐Paul Bohn
American Journal of Hematology 95 ( 9) 1030 -1037

2020
Extending the Dynamic Range in Metabolomics Experiments by Automatic Correction of Peaks Exceeding the Detection Limit

Jan Lisec , Friederike Hoffmann , Clemens Schmitt , Carsten Jaeger
Analytical Chemistry 88 ( 15) 7487 -7492

12
2016
Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8+ T cells

Andrew D Kaiser , Kerstin Schuster , Jules Gadiot , Lisa Borkner
European journal of immunology 42 ( 3) 662 -671

26
2012
Initiation of acute graft-versus-host disease by angiogenesis

Katarina Riesner , Yu Shi , Angela Jacobi , Martin Kräter
Blood, The Journal of the American Society of Hematology 129 ( 14) 2021 -2032

71
2017
Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation.

CA Schmitt , KR Thaler , BM Wittig , H Kaulen
British Journal of Cancer 77 ( 4) 588 -594

21
1998
Metabolism in Cancer

EC Lien , CA Lyssiotis , LC Cantley , T Cramer
Springer 39 -72

10
2016
DNA damage responses and chemosensitivity in the Eµ-myc mouse lymphoma model

CA Schmitt , RR Wallace-Brodeur , CT Rosenthal , ME McCurrach
Cold Spring Harbor Symposia on Quantitative Biology 65 499 -510

32
2000
1999
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.

C. Bouchard , S. Lee , V. Paulus-Hock , C. Loddenkemper
Genes & Development 21 ( 21) 2775 -2787

110
2007
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations

H. Jing , J. Kase , J. R. Dorr , M. Milanovic
Genes & Development 25 ( 20) 2137 -2146

76
2011
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53

C. A. Schmitt , M. E. McCurrach , E. de Stanchina , R. R. Wallace-Brodeur
Genes & Development 13 ( 20) 2670 -2677

578
1999
Cellular senescence predicts treatment outcome in metastasised colorectal cancer.

A M Haugstetter , C Loddenkemper , D Lenze , J Gröne
British Journal of Cancer 103 ( 4) 505 -509

61
2010
EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia

E Young , D Noerenberg , L Mansouri , V Ljungström
Leukemia 31 ( 7) 1547 -1554

28
2017